Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 2131468
PUBLISHER: BCC Research | PRODUCT CODE: 2131468
Global Gene Transfer Technologies Market
PUBLISHED:
PAGES: 81 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
This report provides an overview of the global gene transfer technologies market, analyzing key market trends, growth drivers, challenges, and emerging technologies. The market is segmented by vector type, application, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study also evaluates the impact of PESTEL factors, while offering strategic insights into the competitive landscape and profiles of leading companies. Market forecasts are provided through 2031.
Report Scope
This brief report offers an overview of the global gene transfer technologies market and examines market trends. It includes worldwide revenue (in millions of dollars) for the base year 2025 and forecast data from 2026 to 2031. The market is segmented by delivery methods/mode into viral vectors, non-viral vectors, and physical techniques. Physical methods are sub-segmented into electroporation, gene guns, and microinjection. Based on application, the market segments include gene therapy, cell therapy, vaccines, and research. The regions analyzed in this study are North America, Europe, Asia-Pacific, and the Rest of the World.
The report focuses on key trends, challenges, and technological advances shaping the market and vendor landscape. The report concludes with an analysis of the competitive landscape of prominent companies in the global gene transfer technologies market. It also has a dedicated section of company profiles that covers details such as overview, product portfolio, and strategic developments of key companies in the market.
Report Includes
- An overview and analysis of the global market for gene transfer technologies
- Analyses of global market trends, with revenue data for 2025, estimates for 2026, and projections of CAGRs through 2031 (in $ Millions)
- Estimates of the current market size and revenue growth prospects for the global market, along with a market share analysis by mode, application and region
- Facts and figures related to market dynamics, including drivers, restraints and opportunities influencing the market
- Discussion of emerging technologies and developments in gene transfer technologies
- Competitive intelligence, including strategic analysis of key companies operating in the market
- Profiles of leading companies in the global gene transfer technologies market
Product Code: BIO278A
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Market Definition
- Technology Background
- Viral Vector Gene Delivery Systems
- Non-viral Vector Gene Delivery Systems
- Physical Methods
- PESTEL Analysis
- Impact of U.S. Tariff Laws on the Gene Transfer Technologies Market
- Effects on Supply Chain
- Opportunities for Local Production
- Conclusion
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Growing Cell and Gene Therapy Market
- Rising Prevalence of Chronic Diseases
- Market Restraints
- Lack of Skilled Workforce
- Production Scalability Issues
- Market Opportunities
- Advances in Gene Editing Technologies
- Increasing Collaborations and Partnerships
Chapter 4 Emerging Technologies and Developments
- Overview
- CRISPR/ Cas9 Genome Editing
- Artificial Intelligence in Gene Transfer Technology
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown by Mode
- Key Takeaways
- Viral Vectors
- Non-viral Vectors
- Physical Methods
- Market Breakdown by Application
- Key Takeaways
- Gene Therapy
- Research
- Cell Therapy
- Vaccines
- Geographic Breakdown
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Key Takeaways
- Leading Companies in the Gene Transfer Technologies Market
- Strategic Analysis
- Key Strategies of Prominent Companies in the Gene Transfer Technologies Market
Chapter 7 Appendix
- Methodology
- Abbreviations
- References
- Company Profiles
- 4D MOLECULAR THERAPEUTICS
- BIO-RAD LABORATORIES INC.
- CREATIVE BIOLABS
- LONZA
- MAXCYTE
- MERCK KGAA
- OXFORD BIOMEDICA PLC
- QIAGEN
- SARTORIUS AG
- THERMO FISHER SCIENTIFIC INC.
Product Code: BIO278A
List of Tables
- Summary Table : Global Market for Gene Transfer Technologies, by Region, Through 2031
- Table 1 : Key Research Collaborations and Partnerships
- Table 2 : Global Market for Gene Transfer Technologies, by Mode, Through 2031
- Table 3 : Viral Vectors in Gene Therapy Products
- Table 4 : Approved Viral Vector-based Gene Therapy Products
- Table 5 : Global Market for Gene Transfer Technologies for Viral Vectors, by Region, Through 2031
- Table 6 : Global Market for Gene Transfer Technologies for Non-Viral Vectors, by Region, Through 2031
- Table 7 : Global Market for Gene Transfer Technologies for Physical Methods, by Region, Through 2031
- Table 8 : Global Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
- Table 9 : Global Market for Gene Transfer Technologies for Electroporation, by Region, Through 2031
- Table 10 : Global Market for Gene Transfer Technologies for Microinjection, by Region, Through 2031
- Table 11 : Global Market for Gene Transfer Technologies for Gene Gun, by Region,Through 2031
- Table 12 : Global Market for Gene Transfer Technologies, by Application, Through 2031
- Table 13 : Global Market for Gene Transfer Technologies for Gene Therapy, by Region, Through 2031
- Table 14 : Global Market of Gene Transfer Technologies for Research, by Region, Through 2031
- Table 15 : Global Market of Gene Transfer Technologies for Cell Therapy, by Region, Through 2031
- Table 16 : Global Market of Gene Transfer Technologies for Vaccines, by Region, Through 2031
- Table 17 : Global Market for Gene Transfer Technologies, by Region, Through 2031
- Table 18 : North American Market for Gene Transfer Technologies, by Mode, Through 2031
- Table 19 : North American Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
- Table 20 : North American Market for Gene Transfer Technologies, by Application, Through 2031
- Table 21 : European Market for Gene Transfer Technologies, by Mode, Through 2031
- Table 22 : European Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
- Table 23 : European Market for Gene Transfer Technologies, by Application, Through 2031
- Table 24 : Asia-Pacific Market for Gene Transfer Technologies, by Mode, Through 2031
- Table 25 : Asia-Pacific Market of Gene Transfer Technologies for Physical Methods, by Type, Through 2031
- Table 26 : Asia-Pacific Market for Gene Transfer Technologies, by Application, Through 2031
- Table 27 : RoW Market for Gene Transfer Technologies, by Mode, Through 2031
- Table 28 : RoW Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
- Table 29 : RoW Market for Gene Transfer Technologies, by Application, Through 2031
- Table 30 : Vector Manufacturing Portfolio of Key Companies in the Gene Transfer Technologies Market
- Table 31 : Recent Developments: Gene Transfer Technologies Market, 2023-2026
- Table 32 : Abbreviations Used in this Report
- Table 33 : 4D Molecular Therapeutics: Company Snapshot
- Table 34 : 4D Molecular Therapeutics: Financial Performance, FY 2024 and 2025
- Table 35 : 4D Molecular Therapeutics: Product Portfolio
- Table 36 : 4D Molecular Therapeutics: News/Key Developments, 2023-2025
- Table 37 : Bio-Rad Laboratories Inc.: Company Snapshot
- Table 38 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2024 and 2025
- Table 39 : Bio-Rad Laboratories Inc.: Product Portfolio
- Table 40 : Bio-Rad Laboratories Inc.: News/Key Developments, 2025
- Table 41 : Creative Biolabs: Company Snapshot
- Table 42 : Creative Biolabs: Product Portfolio
- Table 43 : Creative Biolabs: News/Key Developments, 2025-2026
- Table 44 : Lonza: Company Snapshot
- Table 45 : Lonza: Financial Performance, FY 2024 and 2025
- Table 46 : Lonza: Product Portfolio
- Table 47 : MaxCyte: Company Snapshot
- Table 48 : MaxCyte: Financial Performance, FY 2024 and 2025
- Table 49 : MaxCyte: Product Portfolio
- Table 50 : MaxCyte: News/Key Developments, 2025-2026
- Table 51 : Merck KGaA: Company Snapshot
- Table 52 : Merck KGaA: Financial Performance, FY 2024 and 2025
- Table 53 : Merck KGaA: Product Portfolio
- Table 54 : Merck KGaA: News/Key Developments, 2024
- Table 55 : Oxford Biomedica PLC: Company Snapshot
- Table 56 : Oxford Biomedica PLC: Financial Performance, FY 2024 and 2025
- Table 57 : Oxford Biomedica PLC: Product Portfolio
- Table 58 : Oxford Biomedica PLC: News/Key Developments, 2023-2026
- Table 59 : Qiagen: Company Snapshot
- Table 60 : Qiagen: Financial Performance, FY 2024 and 2025
- Table 61 : Qiagen: Product Portfolio
- Table 62 : Qiagen: News/Key Developments, 2025
- Table 63 : Sartorius AG: Company Snapshot
- Table 64 : Sartorius AG: Financial Performance, FY 2024 and 2025
- Table 65 : Sartorius AG: Product Portfolio
- Table 66 : Sartorius AG: News/Key Developments, 2023-2025
- Table 67 : Thermo Fisher Scientific Inc.: Company Snapshot
- Table 68 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
- Table 69 : Thermo Fisher Scientific Inc.: Product Portfolio
- Table 70 : Thermo Fisher Scientific Inc.: News/Key Developments, 2025
List of Figures
- Summary Figure : Global Market Shares for Gene Transfer Technologies, by Region, 2025
- Figure 1 : PESTEL Analysis: Gene Transfer Technologies Market
- Figure 2 : Market Dynamics of Gene Transfer Technologies
- Figure 3 : Viral Vector-based Cell and Gene Therapy Clinical Trials
- Figure 4 : Investments in Cell and Gene Therapy, by Year
- Figure 5 : Global Market Shares for Gene Transfer Technologies, by Mode, 2025
- Figure 6 : Global Market Shares for Gene Transfer Technologies for Physical Methods, by Type, 2025
- Figure 7 : Global Market Shares for Gene Transfer Technologies, by Application, 2025
- Figure 8 : Global Market Shares for Gene Transfer Technologies, by Region, 2025
- Figure 9 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2025
- Figure 10 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2025
- Figure 11 : LONZA: Revenue Shares, by Business Unit, FY 2025
- Figure 12 : LONZA: Revenue Shares, by Region, FY 2025
- Figure 13 : MAXCYTE: Revenue Shares, by Business Unit, FY 2025
- Figure 14 : MAXCYTE: Revenue Shares, by Country/Region, FY 2025
- Figure 15 : Merck KGaA: Revenue Shares, by Business Unit, FY 2025
- Figure 16 : Merck KGaA: Revenue Shares, by Country/Region, FY 2025
- Figure 17 : Oxford Biomedica PLC: Revenue Shares, by Business Unit, FY 2025
- Figure 18 : Oxford Biomedica PLC: Revenue Shares, by Country/Region, FY 2025
- Figure 19 : QIAGEN: Revenue Shares, by Business Unit, FY 2025
- Figure 20 : QIAGEN: Revenue Shares, by Country/Region, FY 2025
- Figure 21 : Sartorius AG: Revenue Shares, by Business Unit, FY 2025
- Figure 22 : Sartorius AG: Revenue Shares, by Country/Region, FY 2025
- Figure 23 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
- Figure 24 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.